SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 180.74-1.8%1:04 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (24785)8/20/1998 7:22:00 AM
From: Mudcat  Read Replies (6) of 32384
 
>Henry, my point is I have never seen a company reiterate a buy rating at the same time they drastically reduce the next two quarters earnings<<

Hey poodle, since you are always criticizing people and not providing any fact, here is your chance to prove what's in that little mind of yours. You say I know nothing about biotechs because I have never seen a buy rating reiterated when they drastically reduce the next 2 quarters estimates. Well since your so knowledgable, maybe you can provide me one or two examples where this has happened in the past. I doubt you will be able to as you only post to make snide remarks with no content. It appears Lgnd was rated a buy by these brokers even when they were at 18 so how could they not reiterate at 9. What they should have explained is we were telling you this was a buy at 18 its now 9 but we have no reason why so buy so more so we can make more commissions.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext